Martin E. Shmagin is CFO at Urigen Pharmaceuticals, Inc. (UGRP.OB). They have made 8 open-market trades across 1 company since 2009, most recently 2009-06-11.
CIK 0001407236
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
8 open-market purchases totalling $41K since 2009, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| UGRP.OB | 3,138,573 | — |
Shares reported on the most recent Form 4, priced at the 2009-06-15 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| UGRP.OB | BUY | 2009-06-11 | 2009-06-15 | $0.08 | $120 | N/A | N/A | N/A |
| UGRP.OB | BUY | 2009-03-16 | 2009-03-18 | $0.09 | $260 | N/A | N/A | N/A |
| UGRP.OB | BUY | 2009-03-09 | 2009-03-13 | $0.09 | $360 | N/A | N/A | N/A |
| UGRP.OB | BUY | 2009-03-05 | 2009-03-10 | $0.08 | $400 | N/A | N/A | N/A |
| UGRP.OB | BUY | 2009-02-24 | 2009-02-26 | $0.11 | $390 | N/A | N/A | N/A |
| UGRP.OB | BUY | 2009-01-29 | 2009-02-03 | $0.11 | $430 | N/A | N/A | N/A |
| UGRP.OB | BUY | 2009-01-27 | 2009-01-30 | $0.11 | $3K | N/A | N/A | N/A |
| UGRP.OB | BUY | 2009-01-22 | 2009-01-26 | $0.15 | $6K | N/A | N/A | N/A |
| UGRP.OB | BUY | 2009-01-20 | 2009-01-21 | $0.21 | $30K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.